• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MHC Ⅰ类抗原呈递和免疫肽组选择途径的变化。

Variations in MHC class I antigen presentation and immunopeptidome selection pathways.

机构信息

Department of Microbiology and Immunology, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.

出版信息

F1000Res. 2020 Sep 28;9. doi: 10.12688/f1000research.26935.1. eCollection 2020.

DOI:10.12688/f1000research.26935.1
PMID:33014341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7525337/
Abstract

Major histocompatibility class I (MHC-I) proteins mediate immunosurveillance against pathogens and cancers by presenting antigenic or mutated peptides to antigen receptors of CD8+ T cells and by engaging receptors of natural killer (NK) cells. In humans, MHC-I molecules are highly polymorphic. MHC-I variations permit the display of thousands of distinct peptides at the cell surface. Recent mass spectrometric studies have revealed unique and shared characteristics of the peptidomes of individual MHC-I variants. The cell surface expression of MHC-I-peptide complexes requires the functions of many intracellular assembly factors, including the transporter associated with antigen presentation (TAP), tapasin, calreticulin, ERp57, TAP-binding protein related (TAPBPR), endoplasmic reticulum aminopeptidases (ERAPs), and the proteasomes. Recent studies provide important insights into the structural features of these factors that govern MHC-I assembly as well as the mechanisms underlying peptide exchange. Conformational sensing of MHC-I molecules mediates the quality control of intracellular MHC-I assembly and contributes to immune recognition by CD8 at the cell surface. Recent studies also show that several MHC-I variants can follow unconventional assembly routes to the cell surface, conferring selective immune advantages that can be exploited for immunotherapy.

摘要

主要组织相容性复合体 I 类(MHC-I)蛋白通过向 CD8+T 细胞的抗原受体呈递抗原或突变肽以及与自然杀伤(NK)细胞的受体结合来介导针对病原体和癌症的免疫监视。在人类中,MHC-I 分子高度多态性。MHC-I 的变异允许在细胞表面显示数千种独特的肽。最近的质谱研究揭示了个体 MHC-I 变体的肽组的独特和共同特征。MHC-I-肽复合物的细胞表面表达需要许多细胞内组装因子的功能,包括抗原呈递相关转运体(TAP)、tapasin、钙网蛋白、ERp57、TAP 结合蛋白相关(TAPBPR)、内质网氨肽酶(ERAPs)和蛋白酶体。最近的研究提供了对这些因子的结构特征的重要见解,这些因子控制 MHC-I 的组装以及肽交换的机制。MHC-I 分子的构象感应介导细胞内 MHC-I 组装的质量控制,并有助于 CD8 在细胞表面的免疫识别。最近的研究还表明,几种 MHC-I 变体可以遵循非常规的组装途径到细胞表面,赋予选择性免疫优势,可用于免疫治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9178/7525337/d5bc90a24bd9/f1000research-9-29753-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9178/7525337/806f55dbc7be/f1000research-9-29753-g0000.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9178/7525337/d5bc90a24bd9/f1000research-9-29753-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9178/7525337/806f55dbc7be/f1000research-9-29753-g0000.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9178/7525337/d5bc90a24bd9/f1000research-9-29753-g0001.jpg

相似文献

1
Variations in MHC class I antigen presentation and immunopeptidome selection pathways.MHC Ⅰ类抗原呈递和免疫肽组选择途径的变化。
F1000Res. 2020 Sep 28;9. doi: 10.12688/f1000research.26935.1. eCollection 2020.
2
Structure of the human MHC-I peptide-loading complex.人类 MHC-I 肽加载复合物的结构。
Nature. 2017 Nov 23;551(7681):525-528. doi: 10.1038/nature24627. Epub 2017 Nov 6.
3
Tapasin-related protein TAPBPR is an additional component of the MHC class I presentation pathway.TAP 相关蛋白 TAPBPR 是 MHC I 类呈递途径的附加成分。
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3465-70. doi: 10.1073/pnas.1222342110. Epub 2013 Feb 11.
4
Mechanisms of function of tapasin, a critical major histocompatibility complex class I assembly factor.tapasin 作为关键的主要组织相容性复合体 I 组装因子的功能机制。
Traffic. 2010 Mar;11(3):332-47. doi: 10.1111/j.1600-0854.2009.01025.x. Epub 2009 Dec 3.
5
Accessory molecules in the assembly of major histocompatibility complex class I/peptide complexes: how essential are they for CD8(+) T-cell immune responses?主要组织相容性复合体I类/肽复合物组装中的辅助分子:它们对CD8(+) T细胞免疫反应有多重要?
Immunol Rev. 2005 Oct;207:77-88. doi: 10.1111/j.0105-2896.2005.00303.x.
6
Dual role of the peptide-loading complex as proofreader and limiter of MHC-I presentation.肽加载复合物作为 MHC-I 呈递的校对者和限制者的双重作用。
Proc Natl Acad Sci U S A. 2024 May 28;121(22):e2321600121. doi: 10.1073/pnas.2321600121. Epub 2024 May 21.
7
MHC class I assembly: out and about.MHC I类分子组装:走出内质网并四处游走
Trends Immunol. 2008 Sep;29(9):436-43. doi: 10.1016/j.it.2008.06.004.
8
Accessory proteins and the assembly of human class I MHC molecules: a molecular and structural perspective.辅助蛋白与人类I类主要组织相容性复合体分子的组装:分子与结构视角
Mol Immunol. 2003 Jan;39(12):697-706. doi: 10.1016/s0161-5890(02)00261-4.
9
The quality control of MHC class I peptide loading.MHC I类分子肽装载的质量控制
Curr Opin Cell Biol. 2008 Dec;20(6):624-31. doi: 10.1016/j.ceb.2008.09.005. Epub 2008 Oct 29.
10
Preferential interaction of MHC class I with TAPBPR in the absence of glycosylation.在缺乏糖基化的情况下,MHC Ⅰ类与 TAPBPR 的优先相互作用。
Mol Immunol. 2019 Sep;113:58-66. doi: 10.1016/j.molimm.2018.06.269. Epub 2018 Aug 1.

引用本文的文献

1
consHLA: a next generation sequencing consensus-based HLA typing workflow.consHLA:一种基于下一代测序共识的HLA分型工作流程。
BMC Bioinformatics. 2025 Aug 19;26(1):215. doi: 10.1186/s12859-025-06223-z.
2
Effects of Calreticulin Mutations on HLA Class I Expression in Myeloproliferative Neoplasms.钙网蛋白突变对骨髓增殖性肿瘤中HLA I类分子表达的影响
bioRxiv. 2025 Jun 27:2025.06.24.661416. doi: 10.1101/2025.06.24.661416.
3
Synergistic Integration of HDAC Inhibitors and Individualized Neoantigen Therapy (INT): A Next-Generation Combinatorial Approach for Cancer Immunotherapy.

本文引用的文献

1
Structural and dynamic studies of TAPBPR and Tapasin reveal the mechanism of peptide loading of MHC-I molecules.TAPBPR 和 Tapasin 的结构和动力学研究揭示了 MHC-I 分子肽加载的机制。
Curr Opin Immunol. 2020 Jun;64:71-79. doi: 10.1016/j.coi.2020.04.004. Epub 2020 May 8.
2
High throughput pMHC-I tetramer library production using chaperone-mediated peptide exchange.使用伴侣介导的肽交换技术高通量生产 pMHC-I 四聚体文库。
Nat Commun. 2020 Apr 20;11(1):1909. doi: 10.1038/s41467-020-15710-1.
3
A loop structure allows TAPBPR to exert its dual function as MHC I chaperone and peptide editor.
组蛋白去乙酰化酶抑制剂与个性化新抗原疗法(INT)的协同整合:癌症免疫疗法的下一代联合方法
Vaccines (Basel). 2025 May 22;13(6):550. doi: 10.3390/vaccines13060550.
4
Deciphering Antigen Processing Machinery (APM) as One of the Determinants for Responsiveness of Affected Patients towards Anticancer Immunotherapy.解析抗原加工机制(APM)作为受影响患者对抗癌免疫疗法反应性的决定因素之一。
Asian Pac J Cancer Prev. 2024 Dec 1;25(12):4457-4464. doi: 10.31557/APJCP.2024.25.12.4457.
5
Allorecognition Unveiled: Integrating Recent Breakthroughs Into the Current Paradigm.同种异体识别揭秘:将最新突破融入当前范式。
Transpl Int. 2024 Nov 11;37:13523. doi: 10.3389/ti.2024.13523. eCollection 2024.
6
Conformational plasticity of RAS Q61 family of neoepitopes results in distinct features for targeted recognition.RAS Q61 家族新表位的构象可塑性导致了针对其进行靶向识别的独特特征。
Nat Commun. 2023 Dec 11;14(1):8204. doi: 10.1038/s41467-023-43654-9.
7
Mass Spectrometric Profiling of HLA-B44 Peptidomes Provides Evidence for Tapasin-Mediated Tryptophan Editing.利用 HLA-B44 肽组学进行的质谱分析为 TAP 相关蛋白介导的色氨酸编辑提供了证据。
J Immunol. 2023 Nov 1;211(9):1298-1307. doi: 10.4049/jimmunol.2300232.
8
The Toll-like Receptor 7-Mediated Ro52 Antigen-Presenting Pathway in the Salivary Gland Epithelial Cells of Sjögren's Syndrome.干燥综合征唾液腺上皮细胞中Toll样受体7介导的Ro52抗原呈递途径
J Clin Med. 2023 Jun 30;12(13):4423. doi: 10.3390/jcm12134423.
9
Effects of calreticulin mutations on cell transformation and immunity.钙网织蛋白突变对细胞转化和免疫的影响。
J Cell Mol Med. 2023 Apr;27(8):1032-1044. doi: 10.1111/jcmm.17713. Epub 2023 Mar 13.
10
Mass spectrometric profiling of HLA-B44 peptidomes provides evidence for tapasin-mediated tryptophan editing.HLA - B44肽组的质谱分析为塔帕辛介导的色氨酸编辑提供了证据。
bioRxiv. 2023 Feb 27:2023.02.26.530125. doi: 10.1101/2023.02.26.530125.
一个环结构使 TAPBPR 能够发挥其作为 MHC I 伴侣蛋白和肽编辑酶的双重功能。
Elife. 2020 Mar 13;9:e55326. doi: 10.7554/eLife.55326.
4
Multifunctional Chaperone and Quality Control Complexes in Adaptive Immunity.多功能伴侣蛋白和适应性免疫中的质量控制复合物。
Annu Rev Biophys. 2020 May 6;49:135-161. doi: 10.1146/annurev-biophys-121219-081643. Epub 2020 Jan 31.
5
Endogenous TAP-independent MHC-I antigen presentation: not just the ER lumen.内源性 TAP 非依赖性 MHC-I 抗原呈递:不仅仅是内质网腔。
Curr Opin Immunol. 2020 Jun;64:9-14. doi: 10.1016/j.coi.2019.12.003. Epub 2020 Jan 11.
6
A large peptidome dataset improves HLA class I epitope prediction across most of the human population.一个大型的肽组数据集提高了 HLA Ⅰ类抗原表位预测在大多数人群中的性能。
Nat Biotechnol. 2020 Feb;38(2):199-209. doi: 10.1038/s41587-019-0322-9. Epub 2019 Dec 16.
7
Molecular determinants of chaperone interactions on MHC-I for folding and antigen repertoire selection.MHC-I 折叠和抗原库选择中伴侣分子相互作用的分子决定因素。
Proc Natl Acad Sci U S A. 2019 Dec 17;116(51):25602-25613. doi: 10.1073/pnas.1915562116. Epub 2019 Dec 3.
8
Immunosuppression by Mutated Calreticulin Released from Malignant Cells.恶性细胞释放的突变钙网蛋白介导的免疫抑制作用。
Mol Cell. 2020 Feb 20;77(4):748-760.e9. doi: 10.1016/j.molcel.2019.11.004. Epub 2019 Nov 27.
9
The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.人类免疫肽组计划:预测和治疗免疫疾病的路线图。
Mol Cell Proteomics. 2020 Jan;19(1):31-49. doi: 10.1074/mcp.R119.001743. Epub 2019 Nov 19.
10
Distinct Polymorphisms in HLA Class I Molecules Govern Their Susceptibility to Peptide Editing by TAPBPR.HLA Ⅰ类分子中的独特多态性决定了它们对 TAPBPR 介导的肽编辑的易感性。
Cell Rep. 2019 Nov 5;29(6):1621-1632.e3. doi: 10.1016/j.celrep.2019.09.074.